Results 271 to 280 of about 187,246 (326)

Immune Checkpoint Inhibitor‐Related Dysautonomia in Merkel Cell Carcinoma: A Case Report

Cancer Reports, Volume 8, Issue 7, July 2025.
ABSTRACT Background Immune checkpoint inhibitors (ICIs) are monoclonal antibodies that block inhibitory pathways that cancer cells exploit to suppress T‐cell activation. Although immune‐related adverse events (irAEs) linked to ICI therapy are well documented and encompass dermatologic, endocrine, gastrointestinal, hepatic, and neurologic systems, ICI ...
Nidhi Kuchimanchi, Sai Gajula, Elizabeth M. Gaughan, Russell G. Witt   +3 more
wiley   +1 more source

Peripheral T-cell lymphoma-NOS in children and adolescents: a review from the Children's Oncology Group NHL Committee. [PDF]

Blood Adv
Devine KJ, Schwartz L, El-Mallawany NK.
europepmc   +1 more source

CD70: An emerging target for integrated cancer diagnosis and therapy

Clinical and Translational Medicine, Volume 15, Issue 7, July 2025.
CD70 is aberrantly overexpressed in diverse tumours with limited normal tissue expression, making it a compelling diagnostic and therapeutic target. Immuno‐PET/CT facilitates tumour detection, staging, and treatment monitoring. Multiple CD70‐targeted therapies are under early evaluation. Rational combination strategies are emerging to enhance antitumor
Jiatao Hu, Jinxin Li, Bo Yang, Siyi Wang, Yi Bao, Yiren Yang, Kun Qiao, Fei Guo, Xinxin Gan, Linhui Wang   +9 more
wiley   +1 more source

Drug- and Vaccine-Induced Cutaneous T-Cell Lymphoma: A Systematic Review of the Literature. [PDF]

J Skin Cancer
Etesami I, Ansari MS, Pourgholi E, Heidari S, Rafati A, Bahramian S, Danaei B, Demokri S, Fazeli P, Memari H, Mirzaee Godarzee H, Sadeghi B, Vahabi SM.   +12 more
europepmc   +1 more source

A Case Series and Literature Review of Angiosarcoma With Malignant Effusion—A Challenging Cytologic Diagnosis With Dire Prognostic Implications

Diagnostic Cytopathology, Volume 53, Issue 7, Page E119-E126, July 2025.
ABSTRACT Angiosarcoma with malignant effusion is an uncommon yet clinically aggressive presentation, which poses as a diagnostic pitfall with its overlapping cytomorphologic features with metastatic adenocarcinoma. In this article, two cases reported in the literature were reviewed for cytology, immunocytochemistry, and clinical course.
Jamie C. Y. Lam, Iris Y. H. Liu, Joanna K. M. Ng, Joshua J. X. Li   +3 more
wiley   +1 more source

Primary Cutaneous Methotrexate-Associated T-Cell Lymphoproliferative Disorder in the Setting of Autoimmune Disease: A Case Series and Review of the Literature. [PDF]

Am J Dermatopathol
Nocco S, Magro C.
europepmc   +1 more source

Granuloma annulare: not as simple as it seems. [PDF]

, 2010
Parish, Lawrence Charles, Witkowski, Joseph A.   +1 more
core   +1 more source

Impact of Postoperative Radiation Therapy Delay and Treatment Facility Location on Survival in Head and Neck Cancer Patients

Head &Neck, Volume 47, Issue 7, Page 1807-1815, July 2025.
ABSTRACT Background Time from surgery to initiation of postoperative radiation therapy (PORT) of less than 6 weeks was recently instituted as the first quality metric within head and neck cancer care. Methods We performed a retrospective single institution cohort study to investigate predictors of PORT delay and the impact of PORT delay on survival ...
Niketna Vivek, Rahul Sharma, Kavita Prasad, Kyle Mannion, Robert J. Sinard, Alexander Langerman, Eben Rosenthal, Sarah Rohde, Ryan Whitaker, Natalie Lockney, Michael C. Topf   +10 more
wiley   +1 more source

Primary cutaneous CD8+ aggressive epidermotropic cytotoxic T-cell lymphoma with novel FGFR1 fusion treated with pemigatinib. [PDF]

Blood Adv
Torres-Cabala CA, Yescas JA, Zhang Y, Huen A, Sumit G, Tefft K, Tang G, Curry JL, Gunther J, Dabaja B, Iyer S, Miranda RN, Choi J, Nardi V.   +13 more
europepmc   +1 more source

Current Status of Revisions to the Lugano Classification in Lymphoma

Hematological Oncology, Volume 43, Issue 4, July 2025.
ABSTRACT In the decade since publication of the Lugano Classification (Cheson et al, J Clin Oncol 2014,32:3059–3068; Barrington et al, J Clin Oncol 2014, 32:3048–3058), major advances in lymphoma therapy and assessment, including metabolic tumor volume (MTV) and circulating tumor DNA (ctDNA) prompted a workshop at the International Conference on ...
The Organizing Committee of the Lugano Classification Workshop
wiley   +1 more source